TY - JOUR
T1 - Orofacial pain during rest and chewing in dementia patients admitted to acute hospital wards: Validity testing of the orofacial pain scale for non-verbal individuals
AU - van de Rijt, Liza J.M.
AU - Weijenberg, Roxane A.F.
AU - Feast, Alexandra R.
AU - Delwel, Suzanne
AU - Vickerstaff, Victoria
AU - Lobbezoo, Frank
AU - Sampson, Elizabeth L.
PY - 2019/7
Y1 - 2019/7
N2 - Aims: To assess the validity of the resting and chewing components of the recently developed observational diagnostic tool, the Orofacial Pain Scale for Non-Verbal Individuals (OPS-NVI). Methods: This cross-sectional observational study was carried out in two UK hospitals. A total of 56 participants with dementia who were admitted to the acute hospital were observed for 3 minutes during rest and during chewing, and the OPS-NVI was used to identify orofacial pain. Afterwards, the participants were asked about the presence of orofacial pain using self-report pain scales. The sensitivity, specificity, and area under the receiver operating curve (AUROC) of the OPS-NVI were calculated for each activity. Spearman coefficient was calculated to assess the correlation between the number of positively scored behavior items of the OPS-NVI and the presence of orofacial pain according to self-report. Results: According to the OPS-NVI, orofacial pain was present in 5.4% of participants during rest and in 9.1% during chewing. According to self-report, the prevalence of orofacial pain was 5.4% during rest and 10.7% during chewing. The specificity of the OPS-NVI was 98.1% to 100%, the sensitivity was 66.7% to 83.3%, and the AUROC was 0.824 to 0.917. The predictive validity showed a strong correlation (0.633 to 0.930, P < .001) between the number of positive behavior items and the self-reported presence of orofacial pain. Conclusion: The resting and chewing components of the OPS-NVI showed promising concurrent and predictive validity. Nevertheless, further validation is required and highly recommended.
AB - Aims: To assess the validity of the resting and chewing components of the recently developed observational diagnostic tool, the Orofacial Pain Scale for Non-Verbal Individuals (OPS-NVI). Methods: This cross-sectional observational study was carried out in two UK hospitals. A total of 56 participants with dementia who were admitted to the acute hospital were observed for 3 minutes during rest and during chewing, and the OPS-NVI was used to identify orofacial pain. Afterwards, the participants were asked about the presence of orofacial pain using self-report pain scales. The sensitivity, specificity, and area under the receiver operating curve (AUROC) of the OPS-NVI were calculated for each activity. Spearman coefficient was calculated to assess the correlation between the number of positively scored behavior items of the OPS-NVI and the presence of orofacial pain according to self-report. Results: According to the OPS-NVI, orofacial pain was present in 5.4% of participants during rest and in 9.1% during chewing. According to self-report, the prevalence of orofacial pain was 5.4% during rest and 10.7% during chewing. The specificity of the OPS-NVI was 98.1% to 100%, the sensitivity was 66.7% to 83.3%, and the AUROC was 0.824 to 0.917. The predictive validity showed a strong correlation (0.633 to 0.930, P < .001) between the number of positive behavior items and the self-reported presence of orofacial pain. Conclusion: The resting and chewing components of the OPS-NVI showed promising concurrent and predictive validity. Nevertheless, further validation is required and highly recommended.
KW - Dementia
KW - Facial pain
KW - Hospital
KW - Observation
KW - OPS-NVI
KW - Toothache
KW - Validation
UR - http://www.scopus.com/inward/record.url?scp=85070185017&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070185017&partnerID=8YFLogxK
U2 - 10.11607/ofph.2136
DO - 10.11607/ofph.2136
M3 - Article
C2 - 30304081
AN - SCOPUS:85070185017
SN - 2333-0384
VL - 33
SP - 247
EP - 253
JO - Journal of Oral and Facial Pain and Headache
JF - Journal of Oral and Facial Pain and Headache
IS - 3
ER -